Medication info

Marinasol Injection

Prescription medicationInjectionsInjection
Ingredient · strength
L-Isoleucine›5900mgL-Leucine›7700mgL-Lysine Acetate›8700mgL-Methionine›4500mgL-Phenylalanine›4800mgL-Threonine›3400mgL-Tryptophan›1300mgL-Valine›5600mgL-Arginine›8100mgL-Histidine›2400mgL-Alanine›6000mgGlycine›11900mgL-Proline›9500mgL-Serine›5000mgL-Cysteine Hydrochloride Hydrate›200mg
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid filled in a colorless transparent glass bottle with a rubber stopper for infusion.
Packaging
250, 500 milliliters
Approval status
Active

MFDS item code 199200224 · Notified 1992.10.30 · Insurance code 643300681,643300691

Summary

Main use
Nutritional improvement through amino acid supplementation (for hypoproteinemia, before and after surgery, etc.)
Who receives it
Adults · Children
Adult administration
○Adults: Administer by intravenous drip, up to a maximum dose of 1-1. 5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a general rule, administer by intravenous drip at a rate of 30-40 drops per minute.
Child administration
For pediatric patients, elderly patients, and burn patients with high protein requirements, adjust the dose and infusion rate.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Nutritional improvement through amino acid supplementation (for hypoproteinemia, before and after surgery, etc.)

  • Hypoproteinemia
  • malnutrition
View approved original text

Amino acid supplementation is important in cases of hypoproteinemia, malnutrition, and pre- and post-operative situations. In these situations, the supply of protein within the body is insufficient or the need is increased, thus amino acids are used to adequately supply them to maintain bodily functions and aid recovery.

How it is given

Adult administration

○Adults: Administer by intravenous drip, up to a maximum dose of 1-1. 5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a general rule, administer by intravenous drip at a rate of 30-40 drops per minute.

Child administration

For pediatric patients, elderly patients, and burn patients with high protein requirements, adjust the dose and infusion rate.

Precautions

This medication must be used according to a doctor's instructions. It should not be administered to patients in hepatic coma or those at risk of hepatic coma. Patients with severe renal impairment or elevated blood nitrogen levels should also not use this medication. Metabolic disorder patients with problems utilizing nitrogen and patients with wasting heart failure should avoid use as well. It should not be used in patients with pulmonary edema or those with very low urine output (oliguria, anuria). This medication is also unsuitable for patients with hypernatremia, hyperchloremia, or alkalosis due to excessive sodium or chloride. Patients with severe acidosis, congestive heart failure, or edema due to sodium retention should be administered with caution. Patients with impaired liver or kidney function should also be cautious, and care should be taken due to allergic reactions or asthmatic attacks that can be caused by sodium bisulfite. Rarely, hypersensitivity reactions such as skin rashes may occur, and in such cases, immediate discontinuation is necessary. Gastrointestinal symptoms such as nausea, vomiting, and cardiovascular symptoms like chest discomfort, palpitations, and elevated blood pressure may occur. Rapid administration may lead to acidosis, so caution is required. Serious reactions such as chills, fever, headache, dyspnea, and shock have also been reported. Metabolic acidosis, electrolyte imbalances, and blood glucose irregularities may occur, so it is essential to monitor these closely. Patients with reduced liver or kidney function may have changes in blood test results, so regular monitoring is needed. When this medication is used in large amounts or in conjunction with electrolyte-containing solutions, care should be taken for electrolyte balance. Overdosage may result in metabolic alkalosis; therefore, special caution is advised. Patients with kidney, lung, or heart diseases should be carefully administered to prevent excessive fluid burden. Diabetic patients should frequently check their blood sugar while using this medication. This medication may be less effective when used with certain antibiotics, so consultation with a physician is necessary. Safety has not been established in pregnant women, so it should only be used when the therapeutic benefit outweighs the risks. In children, lower concentrations should be used as liver function may be immature, and blood ammonia levels should be checked frequently. For the elderly, slower administration rates and dosage adjustments are needed due to impaired physical function. This medication contains electrolytes, so special attention should be given to electrolyte balance during large infusions, and it should be administered slowly via intravenous injection. Fast infusion rates may cause chills or vomiting and could result in significant amino acid excretion via the kidneys. The infusion fluid should be warmed to body temperature and prepared and managed in a sterile state to reduce the risk of infection. If the solution is cloudy or discolored before administration, it should not be used, and care should also be taken during storage.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • difficulty breathing
  • respiratory arrest
  • shock
  • bronchoconstriction
  • ureteral constriction
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes mellitus
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevation of liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • increased BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma
  • anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. The storage location should be at room temperature, neither too hot nor too cold.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid filled in a colorless transparent glass bottle with a rubber stopper for infusion.

Package unit

250, 500 milliliters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.